Naya Biosciences, Stock EBITDA
| NAYA Stock | 0.84 0.01 1.20% |
NAYA Biosciences, fundamentals help investors to digest information that contributes to NAYA Biosciences,'s financial success or failures. It also enables traders to predict the movement of NAYA Stock. The fundamental analysis module provides a way to measure NAYA Biosciences,'s intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to NAYA Biosciences, stock.
NAYA |
NAYA Biosciences, Company EBITDA Analysis
NAYA Biosciences,'s EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, NAYA Biosciences, reported earnings before interest,tax, depreciation and amortization of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Devices industry. The ebitda for all United States stocks is 100.0% higher than that of the company.
NAYA EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses NAYA Biosciences,'s direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of NAYA Biosciences, could also be used in its relative valuation, which is a method of valuing NAYA Biosciences, by comparing valuation metrics of similar companies.NAYA Biosciences, is currently under evaluation in ebitda category among its peers.
About NAYA Biosciences, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze NAYA Biosciences,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NAYA Biosciences, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NAYA Biosciences, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether NAYA Biosciences, offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NAYA Biosciences,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Naya Biosciences, Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Naya Biosciences, Stock:Check out NAYA Biosciences, Piotroski F Score and NAYA Biosciences, Altman Z Score analysis. For information on how to trade NAYA Stock refer to our How to Trade NAYA Stock guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Medical Equipment space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NAYA Biosciences,. If investors know NAYA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NAYA Biosciences, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of NAYA Biosciences, is measured differently than its book value, which is the value of NAYA that is recorded on the company's balance sheet. Investors also form their own opinion of NAYA Biosciences,'s value that differs from its market value or its book value, called intrinsic value, which is NAYA Biosciences,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NAYA Biosciences,'s market value can be influenced by many factors that don't directly affect NAYA Biosciences,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NAYA Biosciences,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if NAYA Biosciences, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NAYA Biosciences,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.